I would like to see the device for the sake of seeing it. But we do know that the machine does have the xray ability and it generates that live as we saw in the video.
We can base the current value of the company on getting that portion of it approved and in my opinion its worth more than .05 a share. I would put it at .15-.19 a share. If and when the demonstration is available then yes we have a .30-.40 a share price.
You have to consider that the value of the stock is in the FDA approval not in its ability to show a machine working on a video clip.
Even if Dean spent the next week working with a production company to show this thing in action and posted it online. You will have people buying into the stock again, but it will NOT hit 1.00 a share.
There will be many unanswered questions after that video comes out. Are we going the 510K or PMA. If its a PMA then no one wants to wait for two years and two additional stock dilution and investor buy in at reduced price (50% of trading price or less now) and therefore people will be sitting on the sidelines watching and waiting for a potential approval to sell the machine.
Sales, Profitability, Margins, and cash on hand makes the stock. well, we one of these (cash) and we have little of it. just enough to carry us for 6 months or so.
A video would be nice to see, but it will not vindicate this stock in any way similar to where it was a year ago nor will it hit the 1.00 mark. Its still un-approved technology!
Market Data 
Markets 
AI
